The LZIC Antibody (PAC010322) is a polyclonal antibody designed for research involving LZIC, a protein known to play a role in liver biology and disease. This antibody, raised in rabbits, is highly reactive with human samples and has been validated for use in various applications, including Western blot and immunohistochemistry.LZIC is a transcriptional regulator that is involved in the development and function of the liver. It has been implicated in liver fibrosis, hepatocellular carcinoma, and other liver diseases, making it a key target for research in the field of liver biology and pathology.
The LZIC Antibody enables researchers to detect and analyze LZIC protein expression in different cell types and tissues, providing valuable insights into its function and potential therapeutic implications.Studying LZIC and its role in liver biology can provide valuable information for the development of novel therapies for liver diseases. By understanding the mechanisms by which LZIC functions in the liver, researchers can potentially identify new targets for drug development and treatment strategies for liver-related disorders.
